LONG MINI-FUTURE - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VV70G49

Market Closed - Deutsche Boerse AG 19:01:45 05/07/2024 BST
16.92 EUR +1.74% Intraday chart for LONG MINI-FUTURE - FRESENIUS MEDICAL CARE
Current month+2.30%
1 month-15.74%
Date Price Change
05/07/24 16.92 +1.74%
04/07/24 16.63 +1.46%
03/07/24 16.39 -0.55%
02/07/24 16.48 -1.26%
01/07/24 16.69 +0.91%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 07:01 pm

More quotes

Static data

Product typeKnock-Out con Stop Loss
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VV70G4
ISINDE000VV70G49
Date issued 07/10/2022
Strike 19.23
Maturity Unlimited
Parity 1 : 1
Emission price 9.49
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 30.67
Lowest since issue 7.3

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.16 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.55%
Consensus